Clinical Trial Update: Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial Epilepsy [Phase 3]

View source ↗

Summary

This clinical trial update reports results from a Phase 3 study of BIA 2-093 in combination with other anti-epileptic drugs for partial epilepsy, with the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial Epilepsy

Drugs mentioned

• BIA 2-093

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Partial Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2013-08-05